Dermatology Imaging Devices Market

Dermatology Imaging Devices Market Size

Dermatology Imaging Devices Market size was valued at USD 2.3 billion in 2023 and is expected to reach USD 6.7 billion by 2032 growing at a CAGR of 12.7% over the analysis period. The market is driven by several factors, including enhanced awareness and timely identification of dermatological issues, continuous advancements in dermatology imaging technologies, and increasing incidence of skin cancer worldwide. Additionally, growing focus on non-invasive diagnostic techniques in dermatology is also contributing towards escalating the growth of the market.

The rising incidence of skin cancer, encompassing melanoma and non-melanoma skin cancers, has spurred the need for dermatology diagnostic devices and imaging devices. These devices are pivotal in early detection, diagnosis, and surveillance of questionable skin lesions, aiding in mitigating the health risks linked to skin cancer. According to the Global Cancer Observatory, in 2022 about 1.2 million incidence of non-melanoma skin cancers was reported globally that is expected to rise to about 1.8 million in 2035.

Dermatology Imaging Devices Market Trends

• The rise of telemedicine and remote monitoring in dermatology, driven by post-pandemic interest in virtual consultations and advancements in tele-dermatology platforms, has led to increased demand for imaging devices facilitating remote imaging, secure data transmission, and teleconsultation, thus improving virtual patient care delivery.
  
• Teledermatology has emerged as a powerful tool for dermatological consultations, leveraging the visual aspects inherent to the specialty. It aids in the early identification and prevention of occupational skin issues.
  
• Smartphone apps like VisualDx, MyDermPath, and YouDermoscopy are making self-monitoring easier, using AI technology, especially for those at higher risk of skin issues.
  

Dermatology Imaging Devices Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on the modality, the global market is classified into dermatoscope, digital photographic imaging, optical coherence tomography, high frequency ultrasound, and other modalities. The dermatoscope segment has asserted its dominance in the global market by securing a significant share and experiencing growth of 12.8% between 2024 – 2032.

• The dominance of dermatoscopy is driven by rising demand for skin cancer diagnosis, advancements in dermatoscope technology, and its proven clinical utility in dermatology.
  
• Dermatoscopy's accuracy exceeds that of conventional clinical exams, particularly in early skin cancer detection and distinguishing between benign and malignant lesions. Consequently, dermatoscopes are considered indispensable in dermatological facilities.
  

Learn more about the key segments shaping this market

Download Free PDF

Based on the application, the dermatology imaging devices market is classified into skin cancers, inflammatory dermatoses, plastic and reconstructive surgery, burn management, and other applications. The inflammatory dermatoses segment is further segmented into skin psoriasis, atopic dermatitis, and other inflammatory dermatoses. The skin cancers segment held the largest market share of 48.8% in 2023.

• This dominance can be attributed to factors such as increasing incidence of skin cancers, growing focus towards early detection and diagnosis of skin cancers, and surge in skin cancer screening programs globally.  
  
• Dermatology imaging tools like dermatoscopes, reflectance confocal microscopy (RCM), and optical coherence tomography (OCT) empower medical professionals to observe skin lesions with heightened precision and clarity. Timely identification and diagnosis of skin cancers, encompassing melanoma and non-melanoma types, are playing a pivotal role in enhancing patient outcomes, thereby promoting the use of dermatology imaging devices in the skin cancer segment.
  

Based on the end user, the dermatology imaging devices market is classified into hospitals, dermatology centers, and speciality clinics. The hospital segment is expected to reach USD 2.9 billion by the end of 2032.

• Hospitals dominate the market due to several key factors. Hospitals typically have advanced healthcare infrastructure and resources, that has made them well-equipped to invest in and utilize sophisticated dermatology imaging devices effectively. Moreover, hospitals often cater to a wide range of patients with diverse dermatological needs, which has resulted in a higher demand for imaging devices for accurate diagnosis and treatment.
  
• Additionally, hospitals have become trusted healthcare institutions for dermatological health related services, where patients are seeking comprehensive care, including dermatological screening, diagnosis and treatments, further driving the demand for imaging devices within these settings.
  

Looking for region specific data?

Download Free PDF

North America region is projected to maintain its lead in the global dermatology imaging devices market, anticipated to reach USD 2.5 billion by 2032.

• North America has emerged as the dominant force in the market, buoyed by several factors including robust healthcare infrastructure, widespread awareness regarding early diagnosis of skin related issues, and rising incidence of skin cancer.
  
• Moreover, easy access to reimbursement and coverage for dermatological issues also helps to drive the demand for dermatological imaging devices, thereby supplementing the market growth.
  

Dermatology Imaging Devices Market Share

The market is fragmented with the presence of considerable number of established and new entrants. The market is characterized by a multitude of medical devices manufacturers offering products targeting diverse aspects of dermatology imaging. Also, the manufacturers are emphasizing towards integrating advanced and innovative technologies and software’s using artificial intelligence and machine learning. This dynamic landscape fosters intense competition, compelling companies to differentiate themselves through product innovation, branding, and marketing strategies to meet the rising demand for dermatology imaging devices.

Dermatology Imaging Devices Market Companies

Prominent players operating in the market are as mentioned below:

• Canfield Scientific, Inc.
• Fotofinder Systems GmbH
• e-con Systems Inc.
• Courage+Khazaka Electronic GmbH
• Longport, Inc.
• Cortex Technology
• Draminski S.A.
• GE Healthcare Technologies, Inc.
• VisualSonics
• Clarius
• Koninklijke Philips N.V.
• Michelson Diagnostics Ltd.
• Caliber Imaging and Diagnosis
• DermLite
• DermaSensor, Inc.
  

Dermatology Imaging Devices Industry News:

• In March 2024, FotoFinder Systems announced the launch of skeen, a first artificial intelligence driven wireless digital dermatoscope with cloud storage. This advanced dermatoscope will offer physicians, an enhanced speed, accuracy and convenience in dermoscopy and trichoscopy using a high-resolution camera, a magnetically attached optical system offering 20x or 40x magnification, an end-to-end wireless workflow, and the AIMEE, the FotoFinder assistant for Artificial Intelligence Mole Examination and Evaluation.
  
• In January 2024, DermaSensor, Inc. announced the FDA approval for the first AI-driven medical tool, DermaSensor, a real-time, non-invasive skin cancer evaluation system designed to identify the three prevalent skin cancers - melanoma, basal cell carcinoma, and squamous cell carcinoma.
  

The dermatology imaging devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Modality

• Dermatoscope
• Optical coherence tomography
• Digital photographic imaging
• High frequency ultrasound
• other modalities

Market, By Application

• Skin cancers
• Inflammatory dermatoses
  • Skin psoriasis
  • Atopic dermatitis
  • Other inflammatory dermatoses
• Plastic and reconstructive surgery
• Burn management
• Other applications

Market, By End User

• Hospitals
• Dermatology centers
• Specialty clinics

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East and Africa